by Russell Noga | Updated April 27th, 2025
For 2026, the Centers for Medicare & Medicaid Services (CMS) has finalized a substantial 5.06% payment increase for Medicare Advantage plan payment increase for 2026. This translates to a $35 billion hike in funding, set to enhance healthcare services for beneficiaries and improve system efficiency. Learn how this update impacts you and the broader Medicare landscape.
Key Takeaways
- Medicare Advantage plans will see a significant payment increase of 5.06% for 2026, translating to an additional $35 billion in total funding.
- CMS finalized adjustments, fully removing medical education costs from Medicare Advantage payment calculations, thereby enhancing payment accuracy and sustainability.
- The new measures aim to improve healthcare accessibility for beneficiaries while reinforcing efficiency and accountability in Medicare, supported by the Inflation Reduction Act.
Compare 2026 Plans & Rates
Enter Zip Code
Overview of the 2026 Payment Policy Updates
The Centers for Medicare & Medicaid Services (CMS) have finalized the payment policies for Medicare Advantage and Part D programs for 2026, marking a pivotal moment in healthcare planning. The agency’s meticulous approach ensures that the new policies are not only beneficial for current Medicare recipients but also sustainable for future generations.
CMS has announced a significant increase in total payments to Medicare Advantage plans, demonstrating its commitment to a sustainable healthcare program. This increase is expected to amount to $35 billion more in 2026 compared to the previous year. Such a substantial boost in funding is set to enhance the quality and accessibility of healthcare services for millions of beneficiaries.
The updated payment policies reflect CMS’s dedication to maintaining an efficient and accountable healthcare system. The agency’s emphasis on payment accuracy and substantive measure specification updates aims to optimize benefits under Medicare Advantage and Part D programs. This strategy ensures efficient resource use and strengthens the program against potential waste and fraud.
Expected Payment Increase for MA Plans in 2026
Medicare Advantage plans are set to receive an average payment increase of 5.06% in 2026, a figure that speaks volumes about the government’s commitment to bolstering these privatized Medicare plans. This increase, up from earlier estimates, highlights the dynamic nature of healthcare funding and the importance of adapting to new data and trends.
With an additional $25 billion in funding expected, beneficiaries of Medicare Advantage plans can look forward to enhanced services and improved healthcare experiences through better medicare alliance. This significant boost is not just a numerical increase; it represents a tangible improvement in the quality of care provided to seniors across the nation.
The role of the Inflation Reduction Act in this context cannot be overlooked. The act plays a crucial part in shaping the future of Medicare Advantage by influencing the Medicare prescription payment plan and related policies. The synergy between legislative measures and CMS’s updates ensures that the benefits of these privatized Medicare plans are maximized for all stakeholders.
Effective Growth Rate for CY 2026
The new payment policies hinge significantly on the effective growth rate for Calendar Year (CY) 2026 advance notice, as indicated in the rate announcement. Set at 9.04%, this rate marks a significant increase from the previous estimate of 5.93%. Such a substantial rise underscores the evolving nature of healthcare costs and the need for adaptive strategies in funding Medicare Advantage plans.
This growth rate is determined by the anticipated growth in Medicare Fee-For-Service (FFS) costs, reflecting changes based on updated data, including recent Medicare FFS payment information. Incorporating the latest data, CMS ensures the payment benchmarks for Medicare Advantage plans are accurate and reflective of current trends.
Adjusting the effective growth rate to 9.04% is key to the overall increase in payments to Medicare Advantage plans. This growth rate not only influences payment benchmarks but also signifies the agency’s commitment to reflecting real-world healthcare costs in its funding strategies. Such meticulous growth rate calculations are essential for maintaining the financial viability of Medicare Advantage plans.
Finalized Adjustments for Medical Education Costs
A significant aspect of the 2026 payment policy updates is the finalized adjustment related to medical education costs. This adjustment marks the completion of a three-year phase-in period, beginning in CY 2024. As of 2026, CMS has fully implemented the removal of medical education costs from the calculations affecting Medicare Advantage payment rates.
This adjustment means that medical education costs will now contribute 100% to the growth rate calculations for Medicare Advantage plans. Incorporating these costs into per capita cost calculations for MA enrollees ensures a more accurate reflection of actual healthcare service expenses.
The phased approach to adjusting medical education costs has been a strategic move by CMS to enhance payment accuracy and ensure that the financial aspects of Medicare Advantage plans are aligned with real-world costs. This technical adjustment is a testament to CMS’s commitment to refining the financial underpinnings of the Medicare Advantage program.
CMS Commitment to Affordable High-Quality Care
The Centers for Medicare & Medicaid Services (CMS) have always been at the forefront of ensuring that Medicare Advantage plans provide affordable, high-quality care. The latest updates are no exception, reinforcing CMS’s dedication to a healthcare system that is both efficient and patient-centered.
A key part of this commitment involves implementing new measure concepts to safeguard beneficiaries and taxpayers from waste, fraud, and abuse. Focusing on these areas, CMS aims to create a high-value healthcare system that delivers safe, effective, and patient-centered care for all.
These updates are not just about financial figures; they represent a broader vision of healthcare where efficiency and accountability are paramount. Under the Biden administration, CMS continues to strive for a system that balances cost-efficiency with high-quality care, ensuring that every dollar spent benefits the beneficiaries and the system as a whole.
Impact on Beneficiaries and Taxpayers
The financial implications of the 2026 payment policy updates are significant for both beneficiaries and taxpayers. Projected total costs for the Medicare program in 2025 are nearing $600 billion, highlighting the substantial taxpayer investment in this crucial program.
Starting in 2026, the annual out-of-pocket threshold for Part D enrollees will be set at $2,100, reflecting adjustments based on previous year’s expenditure trends. This change aims to reduce the financial burden on beneficiaries and ensure that healthcare remains accessible and affordable, including considerations for enrollee cost sharing.
Additionally, new adjustments in coding practices aim to prevent insurers from inflating patient health statuses, leading to more accurate reimbursements and a lesser burden on taxpayers. Changes aimed at closing loopholes in the Medicare Advantage appeals process will now require plans to provide advance notice to both providers and enrollees about coverage decisions, enhancing transparency and accountability, as outlined in the final rule.
Final CY 2026 Part D Redesign Program Instructions
CMS has released the Final CY 2026 Part D Redesign Program Instructions, marking a new chapter in the evolution of Medicare Part D. A key highlight is the introduction of a selected drug subsidy program, which will provide a 10% government subsidy on the negotiated price of certain selected drugs for eligible enrollees, enhancing the drug benefit for participants.
Insurers will need to adapt to new requirements regarding coverage for adult vaccines and insulin products under Medicare Part D, with no cost sharing for these essential services. This change is part of CMS’s broader strategy to ensure that critical medications remain accessible and affordable for all beneficiaries.
Moreover, updates to the Part D risk adjustment models for 2026 will incorporate changes stemming from the Inflation Reduction Act, ensuring that plan sponsors can develop accurate bids. By utilizing more recent data years for Part D risk adjustments, risk adjustment cms aims to enhance the accuracy and efficiency of the Medicare prescription payment plan.
Compare Medicare Plans & Rates in Your Area
Implications for Medicare Advantage Insurers
The finalized payment increase for Medicare Advantage plans has significant implications for insurers, with considerable interaction expected. Higher reimbursement rates are likely to enable these plans to enhance benefits for seniors, potentially increasing enrollment in these plans. This is a crucial step towards making Medicare Advantage more attractive and beneficial for its enrollees.
An important factor influencing the payment increase is the enhanced documentation of diagnosis codes, making Medicare Advantage beneficiaries appear to have greater health issues. This, in turn, leads to higher payments and more resources for these plans to provide better services.
The implementation of new c risk adjustment models is anticipated to increase payment accuracy, directly impacting the affordability and availability of services for seniors. Emphasizing the need for accurate health status information ensures Medicare Advantage plans operate efficiently and effectively, benefiting both beneficiaries and insurers, including the categorical adjustment index.
Historical and Projected Expenditures
Historical and projected expenditures play a crucial role in shaping Medicare Advantage payment policies. The adjustment for medical education costs, previously excluded from these calculations, is now fully incorporated. This change ensures a more accurate reflection of the costs involved in providing healthcare services under Medicare Advantage.
The refinement of the risk adjustment model for Medicare Advantage has been a phased process, spanning over three years and culminating in 2026. This phased approach allows for a smooth transition and ensures that the adjustments are effectively integrated into the payment calculations, including ma risk adjustment model.
As CMS completes this phase-in, the implications for future expenditures are significant. Accurately reflecting real costs and incorporating additional data ensures that funding for Medicare Advantage plans is both adequate and efficient. This approach not only benefits the plans but also ensures that taxpayer money is used judiciously.
Technical Adjustments and Normalization Factors
The technical adjustments included in the 2026 payment policies are designed to enhance the accuracy of spending calculations. One of the key adjustments is the removal of medical education costs related to Medicare Advantage to calculate separate these costs from other calculations. This change ensures that the spending calculations are more reflective of the actual costs incurred by these plans, including substantive measure specification changes.
The effective growth rate’s adjustment is influenced by technical factors related to medical education costs for MA enrollees. Incorporating these costs into growth rate calculations ensures that the payment benchmarks are accurate and reflective of real-world data, based on initial feedback.
The Fee-for-Service normalization factor plays a crucial role in adjusting risk scores for Medicare Advantage. This factor reflects expected growth in average risk score over time, ensuring that the risk adjustment models remain accurate and effective. Using multiple linear regression methodology and other advanced techniques enhances the precision of risk scores and overall payment accuracy, with the risk score calculated being a key component.
Compare 2026 Plans & Rates
Enter Zip Code
Summary
In summary, the finalized payment increase for Medicare Advantage plans for 2026 represents a significant step forward in healthcare funding. With an average payment increase of 5.06%, a new effective growth rate of 9.04%, and the completion of the medical education cost adjustment, CMS is paving the way for a more accurate and sustainable Medicare Advantage program.
These updates highlight CMS’s commitment to providing affordable, high-quality care while safeguarding beneficiaries and taxpayers from waste, fraud, and abuse. By enhancing payment accuracy and refining risk adjustment models, CMS ensures that the benefits of Medicare Advantage plans are maximized for all stakeholders.
As we look to the future, it is clear that these changes will have a profound impact on the Medicare Advantage and Part D programs. By focusing on efficiency, accountability, and patient-centered care, CMS is setting the stage for a brighter and more sustainable healthcare system.
Frequently Asked Questions
What did CMS release on April 7, 2025, regarding Medicare Advantage and Part D programs?
CMS released the Calendar Year (CY) 2026 Rate Announcement, finalizing payment policies for Medicare Advantage and Part D programs. This announcement is crucial for understanding the financial framework for these services.
What is the expected average payment increase from the government to MA plans from 2025 to 2026?
The expected average payment increase from the government to MA plans from 2025 to 2026 is 5.06%.
What is the effective growth rate set for CY 2026, and how does it compare to the previous estimate?
The effective growth rate for CY 2026 is set at 9.04%, representing an increase from the previous estimate of 5.93%. This adjustment indicates a stronger anticipated growth trajectory.
What significant adjustment will CMS complete for CY 2026 regarding medical education costs?
CMS will fully implement the adjustment for Medicare Advantage-related medical education costs in CY 2026, marking the conclusion of a three-year phase-in process. This change is significant for providers as it enhances the financial support for medical education.
What is CMS’s commitment regarding Medicare Advantage?
CMS is dedicated to enhancing access to affordable, high-quality care in Medicare Advantage while protecting beneficiaries and taxpayers from waste, fraud, and abuse. Their approach prioritizes the well-being of both individuals and the overall healthcare system.
Russell Noga is the CEO and Medicare editor of Medisupps.com. His 15 years of experience in the Medicare insurance market includes being a licensed Medicare insurance broker in all 50 states. He is frequently featured as a featured as a keynote Medicare event speaker, has authored hundreds of Medicare content pages, and hosts the very popular Medisupps.com Medicare Youtube channel. His expertise includes Medicare, Medigap insurance, Medicare Advantage plans, and Medicare Part D.